Method for modulating proopiomelanocortin synthesis in a mammal
CA 2117599 C · Owner: Eberwine, James H. · Inventors: Eberwine, James H.; Spencer, Corinne
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention provides a novel method for decreasing proopiomelanocortin (POMC) synthesis in a mammal such as a human comprising administering to the mammal an effective amount of a molecule capable of binding to a mammalian POMC mRNA stem loop structure. The invention further provides a method for increasing POMC synthesis in a mammal comprising administering to the mammal an effective amount of an mRNA POMC stem-loop structure. A method of identifying compounds capable of modulating POMC synthesis in a mammal is also provided. The method comprises identifying compounds which bind to a proopiomelanocortin mRNA stem-loop structure.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 18, 1993 and granted July 29, 2003. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended February 18, 2013.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 18, 2015.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.